Key result
AT1R A1166C polymorphism is linked to modestly higher essential hypertension risk in Chinese populations.
Why the study?
To explore the association between the angiotensin II type 1 receptor A1166C gene polymorphism and susceptibility to essential hypertension within the Chinese population.
Is the angiotensin II type 1 receptor (AT1R) A1166C gene polymorphism associated with susceptibility to essential hypertension in the Chinese population?
Meta-Analysis (n=13,707)
Is the angiotensin II type 1 receptor (AT1R) A1166C gene polymorphism associated with susceptibility to essential hypertension in the Chinese population?
p-value: p=0.04
The AT1R A1166C gene polymorphism may modestly increase susceptibility to essential hypertension in the Chinese population, though regional and ethnic factors influence this association.
May guide genetic risk stratification for EH in Chinese patients; leaves open causal validation and clinical utility.
No takes yet. Share an insight, caveat, or question.
Gu et al. (2026) conducted a meta-analysis in Essential hypertension (n=13,707). AT1R A1166C gene polymorphism vs. Healthy controls was evaluated on Susceptibility to essential hypertension (p=0.04). The AT1R A1166C polymorphism may modestly contribute to essential hypertension susceptibility in the Chinese population (P=0.04).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: